drugIndia
Cart

Rayglim-M1/1000 · Rx · Tablets · 10 × 10Two molecules, two release rates, one bilayer tablet.

Rayglim-M1/1000 holds Glimepiride 1 mg IP and extended-release Metformin Hydrochloride 1000 mg IP in separate layers of a single uncoated tablet, so each releases on its own schedule.

Read the composition

MRP ₹85 · 15% off · strip of 10 tablets, incl. taxes · Rx required, verified at checkout · Trade enquiry · Full listing

Rayglim-M1/1000 carton — 10 × 10 tablets
Blister of 10 · carton of 10 × 10

Schedule H prescription drug. Intended for registered medical practitioners and trade partners — not to be sold by retail without a prescription.

Composition, quality and pack

Glimepiride

Indian Pharmacopoeia · immediate release
1 mg

Metformin HCl

Indian Pharmacopoeia · extended release
1000 mg

Excipients

Colour: Erythrosine
q.s.

Each uncoated bilayer tablet contains

Glimepiride IP 1 mg in the immediate-release layer and Metformin Hydrochloride IP 1000 mg in the extended-release layer, with Erythrosine as colour and excipients q.s. The two layers are formed separately, so the immediate-release portion and the extended-release matrix do not interfere with each other.

Read the safety notice

How the tablet is built and handled

Everything a pharmacist or prescriber needs to check at a glance — the layer structure, the release behaviour, and the storage conditions printed on the carton.

Bilayer coreImmediate releaseExtended releaseUncoatedIP standardsAlu-PVC blisterCool, dry placeProtect from lightProtect from moistureSchedule H
Bilayer tablet, side viewCross-section
  • 1Glimepiride IP 1 mgLayer 1 · immediate release
  • 2Metformin HCl IP 1000 mgLayer 2 · extended-release matrix
Illustrative cross-section, not to scale.

Dosage and administration

From the carton
Dose
As directed by the physician
Administration
Swallow whole. Do not chew or crush.
Review
Titration set and reviewed by the treating physician

The carton carries no fixed regimen.

Release profile

Illustrative pattern over 24 hours. Not clinical data.

  • GlimepirideImmediate release
  • Metformin HClExtended release
GlimepirideMetformin HCl0 h6 h12 h18 h24 hHighLow
One tablet, two release profiles.
“ Tablets should be swallowed whole. They are not to be chewed or crushed. ”
Printed on the carton panel · 1/3

Storage on the shelf

  • Cool, dry and dark
  • Protect from light
  • Protect from moisture
  • Out of reach of children

Common questions

Answers restate the product record. Dosing, suitability and interactions for an individual patient remain the treating physician's decision.

Schedule H prescription drug — Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

No self-medication

Diabetes therapy is initiated, dosed and reviewed by a physician. Do not start, stop or change a dose on the basis of anything read here.

Full prescribing information

Indications, contraindications, interactions, warnings and adverse reactions are carried in the approved pack insert supplied with every carton.

Report an adverse event

Suspected adverse reactions should be reported to the treating physician and to the marketer through the contact channels on this site.

Read the pack

Batch number, manufacturing date, expiry date, licence number and MRP are printed on each carton and blister. Check them before dispensing.

Rayglim-M1/1000 — Metformin HCl Extended Release and Glimepiride Tablets IP. Manufactured in India by Dexbio Pharma Pvt. Ltd. (an ISO & GMP certified company), Khasra No. 3, 4, 5 and part of 4M / Plot No. 134/2, Shiv Ganga Industrial Estate, Lakeshwar, Bhagwanpur, Distt. Haridwar 247661 (Uttarakhand). Marketed by Rayax DrugIndia. Licence number, batch, manufacturing and expiry dates and MRP as printed on the carton. See the full Rayax DrugIndia range